Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis?
There was no statistically significant difference in survival outcomes between the GEP-NET groups located in the gastrointestinal tract and the hepatopancreatobiliary system.
Authors
- Hatice Şeneldir (ORCID: https://orcid.org/0000-0002-1429-6776)
- Muhammet Ali Aydemir (ORCID: https://orcid.org/0000-0003-0240-0924)
- Fatih BÜYÜKER (ORCID: https://orcid.org/0000-0002-7567-3117)
- Hakan Baysal (ORCID: https://orcid.org/0000-0003-3604-6177)
- Tunç Eren (ORCID: https://orcid.org/0000-0001-7651-4321)
- Mehmet Sait Özsoy (ORCID: https://orcid.org/0000-0003-2935-8463)
- Özgür Ekinci (ORCID: https://orcid.org/0000-0002-2020-1913)
- Cem Ilgın Erol (ORCID: https://orcid.org/0000-0002-0955-9615)
- Orhan Ali̇moğlu (ORCID: https://orcid.org/0000-0003-2130-2529)
Institutions
- Erzurum Regional Training and Research Hospital (TR)
- Istanbul Medeniyet University (TR)
Publication Details
- Journal
- Archives of Iranian Medicine
- Published
- 2024-12-30
- DOI
- https://doi.org/10.34172/aim.33366
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.39